eli lilly ceo explains supply chain of covid-19 antibody drug
Published 3 years ago • 1.7K plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
9:22
eli lilly ceo discusses its coronavirus antibody drug and the latest on its breast cancer treatment
-
6:05
eli lilly ceo david ricks on q2 results: seeing unbelievable demand for zepbound and mounjaro
-
4:39
eli lilly ceo on how covid-19 antibody drug helped drive q4 earnings
-
6:52
eli lilly antibody drug will reduce hospitalizations: ceo
-
2:13
eli lilly ceo on covid antibody treatment's effectiveness against mutations
-
1:44
eli lilly confirms it has paused one of its covid-19 antibody tests
-
5:32
lilly tests covid-19 antibody drug in nursing home facilities
-
3:33
eli lilly reports results from covid-19 phase 2 antibody drug trial
-
4:51
the market is non-directional right now, says aperture investors ceo peter kraus
-
5:50
the labor market is slowing slightly but healthy overall, says evercore's roger altman
-
4:03
weekly jobless claims fall to 233,000, less than expected, in a positive sign for labor market
-
4:37
eli lilly ceo: covid-19 antibody treatment will help reduce hospitalizations
-
6:52
eli lilly covid antibody drug cost based on nation's wealth, says ceo
-
2:47
eli lilly hopes to start testing coronavirus cure 'this summer': ceo
-
1:15
eli lilly starts late-stage trial for covid-19 antibody drug in nursing homes
-
8:21
eli lilly ceo talks partnering with abcellera biologics to co-develop a coronavirus cure
-
6:49
coronavirus: eli lilly ceo david ricks on development of therapies
-
3:32
eli lilly ceo david ricks on the end of antibody study in hospitalized patients
-
2:41
eli lilly reports positive phase 3 trial results for covid antibody drug
-
5:19
watch cnbc's interview with eli lilly's chief scientific officer on the new covid-19 antibody drug
-
4:45
supply chain pressures are rather modest in the pharma sector, says eli lilly ceo
-
1:05
eli lilly files for emergency use authorization of its covid-19 antibody drug